Literature DB >> 22207455

Vasoactive intestinal peptide enhances TNF-α-induced IL-6 and IL-8 synthesis in human proximal renal tubular epithelial cells by NF-κB-dependent mechanism.

Ling Huang1, Yiting Tang, Jiao Qin, Yu Peng, Qiongjing Yuan, Fangfang Zhang, Lijian Tao.   

Abstract

Vasoactive intestinal polypeptide (VIP) is a 28-amino acid neuropeptide with vasodilator, bronchodilator, and anti-inflammatory effects. But little is known about its pro-inflammatory effects. We investigated the effect of VIP on the secretion of interleukin-6 (IL-6) and interleukin-8 (IL-8), two pro-inflammatory cytokines, in TNF-α-activated proximal renal tubular epithelial cell line (HK-2 cells). Cultured HK-2 cells were treated with TNF-α in the presence or absence of VIP with a dose range from 1 to 100 nM, followed by analysis of pro-inflammatory cytokines (IL-6 and IL-8) induction and their signal events including activation of the NF-κB pathway. We report here that tumor necrosis factor-α (TNF-α) increased IL-6 and IL-8 production, and that these effects were potentiated by VIP at 10 nM in HK-2 cells. However, VIP at 1 and 100 nM did not display this function. Consistent with these observations, we were able to show that VIP at 10 nM upregulated TNF-α-induced phosphorylation of IκB-α, leading to IκB-α degradation and the subsequent nuclear translocation of NF-κB. Furthermore, VIP-enhanced activation of NF-κB transcription activity was demonstrated using a NF-κB reporter construct upon transient transfection into HK-2 cells. These results strongly suggest that VIP synergistically enhances TNF-α-stimulated IL-6 and IL-8 synthesis via activating the NF-κB pathway in HK-2 cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22207455     DOI: 10.1007/s10753-011-9423-4

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  39 in total

1.  The pituitary adenylate cyclase activating polypeptide (PACAP I) and VIP (PACAP II VIP1) receptors stimulate inositol phosphate synthesis in transfected CHO cells through interaction with different G proteins.

Authors:  J Van Rampelbergh; P Poloczek; I Françoys; C Delporte; J Winand; P Robberecht; M Waelbroeck
Journal:  Biochim Biophys Acta       Date:  1997-06-27

2.  Vasoactive intestinal peptide (VIP) induces IL-6 and IL-8, but not G-CSF and GM-CSF release from a human bronchial epithelial cell line.

Authors:  J Mullol; J N Baraniuk; M Pitale; T Benfield; C Logun; C Picado; J H Shelhamer
Journal:  Neuropeptides       Date:  1997-04       Impact factor: 3.286

3.  Biological activities of synthetic peptides corresponding to fragments of and to the entire sequence of the vasoactive intestinal peptide.

Authors:  M Bodanszky; Y S Klausner; S I Said
Journal:  Proc Natl Acad Sci U S A       Date:  1973-02       Impact factor: 11.205

4.  Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions.

Authors:  T B Usdin; T I Bonner; E Mezey
Journal:  Endocrinology       Date:  1994-12       Impact factor: 4.736

5.  NF-kappaB mediated IL-6 production by renal epithelial cells is regulated by c-jun NH2-terminal kinase.

Authors:  Simone de Haij; Astrid C Bakker; Reinier N van der Geest; Guy Haegeman; Wim Vanden Berghe; Jamil Aarbiou; Mohamed R Daha; Cees van Kooten
Journal:  J Am Soc Nephrol       Date:  2005-04-20       Impact factor: 10.121

6.  Synergistic effect of vasoactive intestinal peptides on TNF-alpha-induced IL-6 synthesis in osteoblasts: amplification of p44/p42 MAP kinase activation.

Authors:  Hideo Natsume; Haruhiko Tokuda; Jun Mizutani; Seiji Adachi; Rie Matsushima-Nishiwaki; Chiho Minamitani; Kenji Kato; Osamu Kozawa; Takanobu Otsuka
Journal:  Int J Mol Med       Date:  2010-05       Impact factor: 4.101

7.  Vasoactive intestinal peptide inhibits IL-8 production in human monocytes.

Authors:  Mario Delgado; Doina Ganea
Journal:  Biochem Biophys Res Commun       Date:  2003-02-21       Impact factor: 3.575

8.  Local non-esterified fatty acids correlate with inflammation in atheroma plaques of patients with type 2 diabetes.

Authors:  Sebastián Mas; Roxana Martínez-Pinna; Jose Luis Martín-Ventura; Raul Pérez; Dulcenombre Gomez-Garre; Alberto Ortiz; Arturo Fernandez-Cruz; Fernando Vivanco; Jesús Egido
Journal:  Diabetes       Date:  2010-03-03       Impact factor: 9.461

9.  Altered expression of immune modulator and structural genes in neonatal unilateral ureteral obstruction.

Authors:  Douglas M Silverstein; Brett R Travis; Barbara A Thornhill; Jill S Schurr; Jay K Kolls; Jocelyn C Leung; Robert L Chevalier
Journal:  Kidney Int       Date:  2003-07       Impact factor: 10.612

10.  Vasoactive intestinal peptide induces IL-8 production in human colonic epithelial cells via MAP kinase-dependent and PKA-independent pathways.

Authors:  Férial Toumi; Michel Neunlist; Marc G Denis; Tsvetelina Oreshkova; Christian L Laboisse; Jean-Paul Galmiche; Anne Jarry
Journal:  Biochem Biophys Res Commun       Date:  2004-04-23       Impact factor: 3.575

View more
  7 in total

1.  [Protective effect of dexmedetomidine against perioperative inflammation and on pulmonary function in patients undergoing radical resection of lung cancer].

Authors:  Yuan-Bo Guo; Jin-Dong Xu; Xue-Xia Ji; Jian-Xing Zhang; Jie-Xian Liang; Guo-Bin Zhou
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-12-20

2.  Vasoactive intestinal peptide suppresses macrophage-mediated inflammation by downregulating interleukin-17A expression via PKA- and PKC-dependent pathways.

Authors:  Wen-Zhuo Ran; Liang Dong; Chun-Yan Tang; Yong Zhou; Guo-Ying Sun; Tian Liu; Yong-Ping Liu; Cha-Xiang Guan
Journal:  Int J Exp Pathol       Date:  2015-05-05       Impact factor: 1.925

3.  The peptide lycosin-I attenuates TNF-α-induced inflammation in human umbilical vein endothelial cells via IκB/NF-κB signaling pathway.

Authors:  Xianyao Li; Yaqin Tang; Binbin Ma; Zheng Wang; Jinying Jiang; Shengjie Hou; Shuhang Wang; Jie Zhang; Meichun Deng; Zhigui Duan; Xing Tang; Alex F Chen; Liping Jiang
Journal:  Inflamm Res       Date:  2018-03-10       Impact factor: 4.575

4.  Antiapoptotic effect of a novel synthetic peptide from bovine muscle and MPG peptide on H2O2-induced C2C12 cells.

Authors:  Allur Subramaniyan Sivakumar; Chinzorio Ochirbat; Soo-Hyun Cho; Jieun Yang; Inho Hwang
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-05-14       Impact factor: 2.416

5.  Mefunidone attenuates tubulointerstitial fibrosis in a rat model of unilateral ureteral obstruction.

Authors:  Chunyan Liu; Wenjuan Mei; Juan Tang; Qiongjing Yuan; Ling Huang; Miaomiao Lu; Lin Wu; Zhangzhe Peng; Jie Meng; Huixiang Yang; Hong Shen; Ben Lv; Gaoyun Hu; Lijian Tao
Journal:  PLoS One       Date:  2015-06-04       Impact factor: 3.240

6.  Vasoactive Intestinal Peptide Deficiency Is Associated With Altered Gut Microbiota Communities in Male and Female C57BL/6 Mice.

Authors:  Manpreet Bains; Caleb Laney; Annie E Wolfe; Megan Orr; James A Waschek; Aaron C Ericsson; Glenn P Dorsam
Journal:  Front Microbiol       Date:  2019-12-02       Impact factor: 5.640

7.  Intestinal injury following liver transplantation was mediated by TLR4/NF-κB activation-induced cell apoptosis.

Authors:  Dong-Dong Yuan; Xin-Jin Chi; Yi Jin; Xi Li; Mian Ge; Wan-Ling Gao; Jian-Qiang Guan; Ai-Lan Zhang; Zi-Qing Hei
Journal:  Mol Med Rep       Date:  2015-12-24       Impact factor: 2.952

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.